Pre-Market Movers And Laggers: Jobs Report Impact

$Asana, Inc.(ASAN)$ 

$Marvell Technology(MRVL)$ 

$Zscaler Inc.(ZS)$ 

$Rigel Pharmaceuticals(RIGL)$ 

Marvell Technology – The chip maker’s stock slid 4.9% in the premarket after quarterly sales and profit fell short of Wall Street estimates. Marvell also issued a weaker than expected outlook. Inventory

Zscaler – The cloud security company reported a better than expected quarter, but its stock slumped 9.1% in premarket trading following conservative guidance. Zscaler said customers are taking longer to close new deals, and that it faces other headwinds as well.

Horizon Therapeutics – The drug maker’s shares added 3.2% in premarket action afterSanofi(SNY) said that if it decided to make an offer for Horizon, it would be an all-cash offer. Horizon shares had soared 27.3% last Friday on news that it was in talks with several potential takeover partners.

DoorDash – DoorDash shares fell 2.8% in premarket trading after RBC Capital Markets downgraded the stock to “sector perform” from “outperform.” RBC praises the delivery service’s execution and management but says it is uncomfortable with the current valuation given the potential for order deceleration.

Rigel Pharma – Rigel’s stock soared 34% in the premarket after the FDA approved its drug to treat a certain type of leukemia.

Opendoor Technologies – The digital real estate platform operator named Chief Financial Officer Carrie Wheeler as its new CEO, replacing company co-founder Eric Wu. Wu will transition into the role of “president of marketplace.” Opendoor lost 2.7% in premarket action.

PagerDuty – The cloud computing company’s stock jumped 6.6% in premarket trading after it reported an unexpected quarterly profit.

Asana – The work management platform operator forecast weaker than expected current quarter sales, stemming from what it called “macroeconomic cross currents.” Asana slumped 14.4% in the premarket.

Owens Corning – The building and construction materials maker announced a 50% quarterly dividend increase to 52 cents per share, as well as a buyback program of up to 10 million shares.

# 💰 Stocks to watch today?(10 May)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment246

  • Top
  • Latest
  • SSVC
    ·2022-12-04
    K//@MeHu:[Smile] //@Kelvinphan:Go//@daz888888888:$Rigel Pharmaceuticals(RIGL)$  Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
    Reply
    Report
    Fold Replies
    • boonk
      Oic
      2022-12-04
      Reply
      Report
    • Justriann
      👌
      2022-12-04
      Reply
      Report
    • WKB
      Yeah
      2022-12-04
      Reply
      Report
    View more 58 comments
  • Kelvinphan
    ·2022-12-04
    Go//@daz888888888:$Rigel Pharmaceuticals(RIGL)$  Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
    Reply
    Report
    Fold Replies
    • wmwwmw
      ok
      2022-12-04
      Reply
      Report
    • Andy Kong
      ok
      2022-12-04
      Reply
      Report
    • Big Cat
      [OK]
      2022-12-04
      Reply
      Report
    View more 42 comments
  • MeHu
    ·2022-12-04
    [Smile] //@Kelvinphan:Go//@daz888888888:$Rigel Pharmaceuticals(RIGL)$  Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
    Reply
    Report
    Fold Replies
    • Ruixiang
      Shia
      2022-12-04
      Reply
      Report
    • kwk
      k
      2022-12-04
      Reply
      Report
    • kwk
      k
      2022-12-04
      Reply
      Report
    View more 52 comments
  • daz888888888
    ·2022-12-04

    $Rigel Pharmaceuticals(RIGL)$ 

    Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k.

    While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.

    Reply
    Report
    Fold Replies
    • EKT
      Thanks for sharing!
      2022-12-04
      Reply
      Report
    • Abc123
      Wow
      2022-12-04
      Reply
      Report
    • RichyRickReplying toJenjorjack
      yeah
      2022-12-04
      Reply
      Report
    View more 36 comments
  • KevinToh
    ·2022-12-04
    //@Kelvinphan:Go//@daz888888888:$Rigel Pharmaceuticals(RIGL)$  Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
    Reply
    Report
    Fold Replies
    • Junyuan
      K
      2022-12-04
      Reply
      Report
    • Papa Bear
      thanks
      2022-12-04
      Reply
      Report
    • E1Replying toTheinHtut
      ok
      2022-12-04
      Reply
      Report
    View more 5 comments
  • daz888888888
    ·2022-12-04
    Insiders who bought Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) stock in the last 12 months were richly rewarded last week. The company's market value increased by US$14m as a result of the stock's 11% gain over the same period. As a result, the stock they originally bought for US$688k is now worth US$834k. While we would never suggest that investors should base their decisions solely on what the directors of a company have been doing, we would consider it foolish to ignore insider transactions altogether.
    Reply
    Report
  • alexkho
    ·2022-12-05
    good
    Reply
    Report
  • a1g2r
    ·2022-12-05
    nice
    Reply
    Report
  • FunnyFun
    ·2022-12-04
    Nice
    Reply
    Report
  • Mic6226
    ·2022-12-04
    Good
    Reply
    Report
  • Chloe Goh
    ·2022-12-04
    👍🏻
    Reply
    Report
  • Chloe Goh
    ·2022-12-04
    👍🏻
    Reply
    Report
  • Alberttomoon
    ·2022-12-04
    Ok
    Reply
    Report
  • DancingOwl
    ·2022-12-04
    Oo
    Reply
    Report
  • Ashish
    ·2022-12-04
    nice
    Reply
    Report
  • DancingOwl
    ·2022-12-04
    Ok
    Reply
    Report
  • redmerlion
    ·2022-12-04
    Ok
    Reply
    Report
  • CHEWYY
    ·2022-12-04
    thks
    Reply
    Report
  • LengLeng
    ·2022-12-04
    Ok
    Reply
    Report
  • chang168
    ·2022-12-04
    up
    Reply
    Report